TFX06

· Zhejiang Yangli Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TFX06, covering 2023-07-03 to 2023-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of TFX06 in Women With Advanced Breast Cancer. [Phase 1, Phase 2]